India  

Indian vaccine co had adverse event; experts seek more transparency

IndiaTimes Saturday, 21 November 2020
Hyderabad-based Bharat Biotech’s potential Covid-19 vaccine reported a serious adverse event during clinical trials in August, even as it’s now initiated the Phase 3 stage of the study. The adverse event occurred in a 35-year old participant with no comorbidities, who was part of Phase 1 trials in August, investigators monitoring the study confirmed to TOI on condition of anonymity.
0
shares
ShareTweetSavePostSend
 
Video Credit: Wibbitz Top Stories - Published
News video: Ticketmaster Will Not Enforce Mandatory COVID-19 Vaccine or Testing Requirements

Ticketmaster Will Not Enforce Mandatory COVID-19 Vaccine or Testing Requirements 01:18

Ticketmaster Will Not Enforce Mandatory COVID-19 Vaccine or Testing Requirements. Ticketmaster has come forward to deny false claims that they will require fans to provide proof of COVID-19 vaccine or test. . In a statement released to the BBC, the ticket giant clarified that there would be...

You Might Like


💡 newsR Knowledge: Other News Mentions

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

Jharkhand Police: ₹ 35 lakh as fine from masses violating Covid norms  | Oneindia News [Video]

Jharkhand Police: ₹ 35 lakh as fine from masses violating Covid norms | Oneindia News

Thousands of people including Covid patients evacuated because of Cyclone Tauktae from Gujarat and Maharashtra; Bharat Biotech said that the company manufactured Covaxin is effective against the aggressively virulent strains of Covid detected in India and in the UK; Delhi police said that an Aam Admi Party party member is the brain behind the posters that appeared around parts of Delhi a few days ago; Delhi Chief Minister Arvind Kejriwal today said the Delhi government will take all necessary steps and precautions to check cases of black fungus or mucormycosis in the city; Jharkhand Police has collected over ₹ 35 lakh as fine from people for not wearing masks in public places. #CycloneTauktae #Covaxin #AAP #BlackFungus #JharkhandPolice

Credit: Oneindia    Duration: 03:39Published

Covaxin effectively neutralises all key emerging variants, says study published in Oxford journal

Indigenous Covid-19 vaccine Covaxin has been able to neutralise all key emerging variants, including the double mutant B.1.617 and B.1.1.7, which was first..
IndiaTimes

COVID-19 COVID-19 Disease caused by severe acute respiratory syndrome coronavirus 2

Tauktae now ‘very severe’ cyclone, set to rip into Gujarat at 185kmph

Covid-bruised Gujarat braced for a battering by the strongest cyclone to hit its coast since 1998 as Tauktae, which cut a swathe through the western coastal belt..
IndiaTimes

Study: Covid deaths have affected 82% of elderly with anxiety

Loneliness and a deepening sense of uncertainty has hit the senior citizens like never before during the second wave of Covid-19 pandemic, according to the..
IndiaTimes

‘PM Cares helped triple number of ventilators’

Ventilators allocated to states and Union Territories under PM Cares and the health ministry have more than tripled availability of the critical care machines in..
IndiaTimes

Beat 1st wave, halted 2nd, ready to face 3rd: Yogi Adityanath

Uttar Pradesh CM Yogi Adityanath asserted here on Sunday that the country’s largest state was able to arrest the second surge of Covid-19 and was prepared to..
IndiaTimes

Rs 23,000 crore given to state disaster fund, 50% of it for Covid fight

The Centre has allocated over Rs 23,000 crore towards State Disaster Response Fund (SDRF) for the second successive year in 2021-22, half of which has been..
IndiaTimes

Hyderabad Hyderabad Capital of Telangana, India

Rajnath Singh to release first batch of DRDO's anti-COVID oral drug 2DG today

Developed by DRDO's INMAS, in collaboration with Dr Reddy's Laboratories in Hyderabad, the 2DG drug is an anti-Covid therapeutic application.
DNA

Second batch of Russian Covid-19 vaccine Sputnik V reaches Hyderabad

As the second batch of the Sputnik V landed in Hyderabad, Telangana on Sunday, Russian Ambassador to India, Nikolay Kudashev termed the Russian-Indian fight..
IndiaTimes

Second batch of Russian Covid-19 vaccine Sputnik V arrives in Hyderabad

As the second batch of the Sputnik V landed in Hyderabad, Telangana on Sunday, Russian Ambassador to India, Nikolay Kudashev termed the Russian-Indian fight..
IndiaTimes

Dr Reddy's rolls out Sputnik V Covid-19 vaccine in India at around Rs 995 per dose

Dr Reddy’s Laboratories, the Indian partner of Russian Direct Investment Fund (RDIF), said it has commenced Sputnik V’s India rollout with the first dose..
IndiaTimes

Covid-19: Dr Reddy's rolls out Sputnik V in India at around Rs 995 per dose

Dr Reddy’s Laboratories, the Indian partner of Russian Direct Investment Fund (RDIF), said it has commenced Sputnik V’s India rollout with the first dose..
IndiaTimes

The Times of India The Times of India Indian English-language daily newspaper

India's Covid cases fall but deaths remain high; fatality rate rises in May

Daily cases of Covid-19 in India continued to fall after hitting a peak last week but deaths remained high with close to 4,000 fatalities recorded on Thursday...
IndiaTimes
50 Floor | Morning Blend [Video]

50 Floor | Morning Blend

50 Floor

Credit: ABC Action News    Duration: 03:45Published
Spring Reboot | Morning Blend [Video]

Spring Reboot | Morning Blend

Spring Reboot

Credit: ABC Action News    Duration: 05:11Published
Counsel's Corner | Morning Blend [Video]

Counsel's Corner | Morning Blend

Counsel's corner debt relief

Credit: ABC Action News    Duration: 04:51Published

Related news from verified sources

Mumbai: New and silent COVID-19 symptoms worry doctors

Mumbai: New and silent COVID-19 symptoms worry doctors
The COVID-19 graph has started to slant downwards, but health experts are now concerned about a new trend. Patients are being rushed to emergency rooms without...
Mid-Day

IMA urges the government to collect data of frontline medical warrior as they are at high risk

IMA urges the government to collect data of frontline medical warrior as they are at high risk
While the Indian government has stated that it does not have data on frontline warriors who died fighting COVID-19, a recent study by a medical journal in the UK...
Mid-Day

Mumbai: Unlikely that price cap at hospitals will go, says civic body

After seeing a drop in the city's daily count of COVID-19 cases, private hospitals are hoping that the price cap on 80 per cent of COVID beds will be relaxed...
Mid-Day